Corporate Earnings Roundup: Hindustan Zinc, HFCL & More
Hindustan Zinc reports Q2 sales of Rs 149,610 million, a 75.50% increase year-over-year.
Key Highlights
Explore the Q2 financial results for Hindustan Zinc, HFCL, Piramal Finance, and more. Track sales growth, net profit spikes, and fiscal health.
Corporate financial results for the September 2026 quarter highlight diverse performance metrics across prominent Indian entities including Hindustan Zinc, HFCL, Piramal Finance, Tatva Chintan, and Aksharchem (India). Market desks tracked these updates closely for signals on fiscal health, operational growth, and broader market standing.
Hindustan Zinc Financial Performance
Hindustan Zinc recorded a sharp climb in its September 2026 quarter financials, with topline sales advancing 75.50% to Rs 149,610.00 million compared to Rs 85,250.00 million in the year-ago period.
Key Earnings Metrics
Market participants tracking the corporate earnings slate noted substantial gains across operating profit and net earnings for the mining major.
- : Rs 149,610.00 million, up 75.50% from Rs 85,250.00 million.
- : Vaulted 140.01% to Rs 63,170.00 million from Rs 26,320.00 million.
- PBIDT: Reached Rs 95,070.00 million, showing a 103.88% increase from Rs 46,630.00 million.
- Interest Expenses: Dropped 66.02% to Rs 880.00 million against Rs 2,590.00 million.
Year-to-Date and Annual Figures
For the year-to-date period ending September 2026, cumulative sales reached Rs 286,480.00 million, reflecting a 76.32% growth over the corresponding period last year. for the September 2026 quarter settled at Rs 84,590.00 million, while depreciation rose marginally by 8.97% to Rs 9,600.00 million.
Cross-Sector Corporate Updates
Additional reports from HFCL, Piramal Finance, Tatva Chintan Pharma, and Aksharchem (India) provide further insight into fiscal performance across the telecommunications, financial services, and chemical sectors. Analysts continue to parse these quarterly updates to gauge fundamental momentum across diverse market segments.